Archford Capital Strategies, LLC Abbott Laboratories Transaction History

Archford Capital Strategies, LLC

$611 Million
Q2 2024

A detailed history of Archford Capital Strategies, LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Archford Capital Strategies, LLC holds 3,627 shares of ABT stock, worth $407,094. This represents 0.06% of its overall portfolio holdings.

Number of Shares

3,627

Previous 3,555 2.03%

Holding current value

$407,094

Previous $404,000 6.93%

% of portfolio

0.06%

Previous 0.07%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 17, 2024	BUY	$100.73 - $112.44 $7,252 - $8,095	72 Added 2.03%	3,627 $376,000
Q1 2024 Apr 24, 2024	BUY	$109.52 - $120.96 $33,841 - $37,376	309 Added 9.52%	3,555 $404,000
Q4 2023 Jan 12, 2024	SELL	$90.19 - $110.4 $211,585 - $258,998	-2,346 Reduced 41.95%	3,246 $357,000
Q3 2023 Oct 27, 2023	SELL	$95.53 - $114.62 $16,813 - $20,173	-176 Reduced 3.05%	5,592 $541,000
Q2 2023 Aug 02, 2023	BUY	$100.78 - $112.29 $403 - $449	4 Added 0.07%	5,768 $628,000
Q1 2023 Apr 18, 2023	BUY	$96.86 - $114.01 $144,224 - $169,760	1,489 Added 34.83%	5,764 $583,000
Q4 2022 Jan 26, 2023	SELL	$95.06 - $111.52 $26,616 - $31,225	-280 Reduced 6.15%	4,275 $0
Q3 2022 Oct 17, 2022	BUY	$96.76 - $112.03 $16,642 - $19,269	172 Added 3.92%	4,555 $441,000
Q2 2022 Jul 12, 2022	SELL	$102.07 - $123.37 $207,712 - $251,057	-2,035 Reduced 31.71%	4,383 $476,000
Q1 2022 Apr 18, 2022	SELL	$114.02 - $139.04 $113,107 - $137,927	-992 Reduced 13.39%	6,418 $767,000
Q4 2021 Jan 20, 2022	SELL	$115.53 - $141.46 $29,806 - $36,496	-258 Reduced 3.36%	7,410 $1.04 Million
Q3 2021 Oct 14, 2021	SELL	$116.66 - $129.06 $4,549 - $5,033	-39 Reduced 0.51%	7,668 $906,000
Q2 2021 Jul 23, 2021	SELL	$105.79 - $124.53 $80,083 - $94,269	-757 Reduced 8.94%	7,707 $893,000
Q1 2021 Apr 26, 2021	SELL	$108.84 - $128.23 $850,149 - $1 Million	-7,811 Reduced 47.99%	8,464 $1.05 Million
Q4 2020 Jan 19, 2021	BUY	$105.0 - $114.42 $40,215 - $43,822	383 Added 2.41%	16,275 $1.82 Million
Q3 2020 Oct 19, 2020	SELL	$91.64 - $111.29 $135,352 - $164,375	-1,477 Reduced 8.5%	15,892 $1.73 Million
Q2 2020 Jul 24, 2020	SELL	$76.57 - $98.0 $4,287 - $5,488	-56 Reduced 0.32%	17,369 $1.59 Million
Q1 2020 Apr 29, 2020	BUY	$62.82 - $91.86 $510,412 - $746,362	8,125 Added 87.37%	17,425 $1.38 Million
Q1 2019 May 13, 2019	SELL	$66.22 - $80.06 $15,694 - $18,974	-237 Reduced 2.49%	9,300 $743,000
Q3 2018 Nov 14, 2018	SELL	$60.81 - $73.36 $12,770 - $15,405	-210 Reduced 2.15%	9,537 $700,000
Q2 2018 Aug 14, 2018	BUY	$57.57 - $63.54 $561,134 - $619,324	9,747 New	9,747 $594,000
Q1 2018 May 14, 2018	SELL	$56.27 - $63.62 $549,307 - $621,058	-9,762 Closed	0 $0
Q4 2017 Feb 16, 2018	SELL	$53.68 - $57.47 $9,930 - $10,631	-185 Reduced 1.86%	9,762 $557,000
Q3 2017 Nov 17, 2017	BUY	$48.06 - $53.64 $1,682 - $1,877	35 Added 0.35%	9,947 $531,000
Q2 2017 Aug 25, 2017	BUY	N/A	9,468 Added 2132.43%	9,912 $482,000
Q2 2017 Aug 18, 2017	BUY	N/A	444	444 $55,000

Others Institutions Holding ABT

# of Institutions

3,138

Shares Held

1.33B

Call Options Held

8.63M

Put Options Held

7.17M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $197B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Archford Capital Strategies, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Archford Capital Strategies, LLC with notifications on news.

Account

Archford Capital Strategies, LLC Abbott Laboratories Transaction History